MS. Demyelinating diseases of the central nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Entry Criteria: Confirmation of MS by the center's neurologist; The absence of other neurological disorders and mental and mental disorders, according to the patient's case and opinion; At least six months of diagnosis; Having reading and writing skills or having a companion to complete; the person questionnaire in the age range of 20-45 years; Failure to have liver disease or deficiency in liver enzymes, lack of pregnancy and lactation; Failure to receive complementary and alternative therapies during the past three months. (To reduce anxiety and improve sleep quality.) Exit criteria: No patient incentive to continue cooperation. During the research; To perform this intervention in the past (because of the decrease in the amount of suppression, the probability of answering the questions based on the information stored in the previous study); Not having enough insight into the disease and not having the ability to collaborate in the study; Drug use New sedative and hypnotic; Alcohol users, Barbiturates and Benzodiazepine (in iron users between consumption Valerie N and iron should be 1 to 2 hours apart); Hepatitis and pregnancy ; If not used for 2 days
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep Quality, Anxiety. Timepoint: Befor Intervention- After Intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improve The Quality of Sleep, Reduce Anxiety. Timepoint: Before The Intervention - After The End of Intervention. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Univercity of Social Walfare and Rehabilitation Science